Related Experiment Video
Updated: Feb 13, 2026

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
CD99: A Cell Surface Protein with an Oncojanus Role in Tumors
Maria Cristina Manara1, Michela Pasello2, Katia Scotlandi3
1Laboratory of Experimental Oncology, CRS Development of Biomolecular Therapies, Rizzoli Orthopaedic Institute, 40136 Bologna, Italy. mariacristina.manara@ior.it.
Abstract:
The cell surface molecule CD99 has gained interest because of its involvement in regulating cell differentiation and adhesion/migration of immune and tumor cells. However, the molecule plays an intriguing and dual role in different cell types. In particular, it acts as a requirement for cell malignancy or as an oncosuppressor in tumors. In addition, the gene encodes for two different isoforms, which also act in opposition inside the same cell. This review highlights key studies focusing on the dual role of CD99 and its isoforms and discusses major critical issues, challenges, and strategies for overcoming those challenges. The review specifically underscores the properties that make the molecule an attractive therapeutic target and identifies new relationships and areas of study that may be exploited. The elucidation of the spatial and temporal control of the expression of CD99 in normal and tumor cells is required to obtain a full appreciation of this molecule and its signaling.
Insights
The cell surface molecule CD99 has a dual role in cell behavior, acting as both a malignancy promoter and an oncosuppressor in tumors. Understanding its isoforms and expression is key for therapeutic targeting.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- CD99 is a cell surface molecule involved in immune and tumor cell differentiation, adhesion, and migration.
- CD99 exhibits a dual role, promoting malignancy in some tumors while acting as an oncosuppressor in others.
- The CD99 gene produces two opposing isoforms within the same cell.
Purpose of the Study:
- To review key studies on the dual role of CD99 and its isoforms.
- To discuss challenges and strategies related to CD99 research and therapeutic targeting.
- To identify new research avenues for CD99 and its signaling pathways.
Main Methods:
- Literature review of key studies on CD99.
- Analysis of CD99's dual role in different cell types and tumors.
- Discussion of therapeutic potential and future research directions.
Main Results:
- CD99's function is context-dependent, acting as either an oncogene or oncosuppressor.
- Two isoforms of CD99 exist with opposing intracellular functions.
- CD99 presents an attractive, yet complex, therapeutic target.
Conclusions:
- Further elucidation of CD99's spatial and temporal expression is crucial.
- Understanding CD99's dual role is essential for developing effective cancer therapies.
- Targeting CD99 offers potential for novel therapeutic strategies in oncology.
Related Concept Videos
Role of Proteins in the Human Body
Cell-surface Signaling
Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....
Role of Microtubules in Cell Wall Deposition
The Role of Actin and Myosin in Non-muscle Cells
Protein-protein Interfaces

